Press release
PARP Inhibitors Market to reach USD 11.56 Bn by 2029, emerging at a CAGR of 11.20 percent and forecast 2023-2029
PARP Inhibitors Market
Cancer remains one of the most devastating diseases worldwide, claiming a significant number of lives, according to the World Health Organization. The growing prevalence of cancer has intensified the demand for effective drugs, precision therapies, and targeted medicines. Precision medicines, with their focus on selective cancer cell targeting, have reshaped cancer treatments. Over the past decade, Poly ADP-ribose Polymerases (PARP) have emerged as a new frontier in cancer therapy.
Maximize Market Research Pvt Ltd presents a comprehensive report on the global PARP Inhibitors Market, offering valuable insights into market trends, forecasts, and key players. Our rigorous research methodology ensures accuracy and reliability.
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/request-sample/81566
PARP Inhibitors Market Dynamics:
PARP inhibitors represent a significant breakthrough in precision medicine, effectively targeting specific cancer cells by impeding DNA repair following chemotherapy. The rising incidence of cancer, government funding initiatives, and advanced treatment techniques are propelling the growth of the PARP inhibitors market. Initiatives such as Cancer Australia's "Supporting People with Cancer" grant, providing grants up to $120,000 for projects aimed at reducing the cancer burden, have played a pivotal role in the market's expansion. Additionally, collaborative efforts between organizations to enhance coordination, accessibility, and quality cancer support networks contribute to market growth.
PARP Inhibitors Market Regional Insights:
North America leads the global PARP Inhibitors market due to a rising geriatric population and a high prevalence of diseases and disorders.
The Asia-Pacific (APAC) region is witnessing growth, driven by increased research on BRCA-mutation tumors, ovarian cancer, and improved disease awareness.
Maximize Market Research Pvt Ltd aims to provide a complete understanding of the global PARP Inhibitors Market to all industry stakeholders. Our report covers market size, trends, and a dedicated study of key players, including market leaders, followers, and new entrants. We analyze both external and internal factors that can positively or negatively impact the industry, providing decision-makers with a clear view of its future.
Request For Free Inquiry Report:https://www.maximizemarketresearch.com/inquiry-before-buying/81566
PARP Inhibitors Market Segmentation:
by Drug-type
Lynparza
Niraparib
Rucaparib
Talazoparib
Veliparib
by Indication
Ovarian Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
by Distribution Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/81566
PARP Inhibitors Market Key Players:
1. AstraZeneca
2. Tesaro
3. AbbVie Inc
4. Medivation
5. Clovis Oncology
6. Johnson & Johnson
7. GlaxoSmithKline plc
8. Pfizer Inc
9. Bristol-Myers Squibb
10.Merck KGaA
11.Genentech Inc
12.Repare Therapeutics
13.Sierra Oncology
14.Karyopharm Therapeutics Inc
15.Ono Pharmaceutical Co. Ltd
Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/market-report/global-parp-inhibitors-market/81566/
Table of content for the PARP Inhibitors Market includes:
1. Global PARP Inhibitors Market: Research Methodology
2. Global PARP Inhibitors Market: Executive Summary
• Market Overview and Definitions
• Introduction to the Global Market
• Summary
• Key Findings
• Recommendations for Investors
• Recommendations for Market Leaders
• Recommendations for New Market Entry
3.Global PARP Inhibitors Market: Competitive Analysis
• MMR Competition Matrix
• Market Structure by region
• Competitive Benchmarking of Key Players
• Consolidation in the Market
• M&A by region
• Key Developments by Companies
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Market Dynamics
• PORTERS Five Forces Analysis
• PESTLE
• Regulatory Landscape by region
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America
• COVID-19 Impact
4 . Company Profile: Key players
• Company Overview
• Financial Overview
• Global Presence
• Capacity Portfolio
• Business Strategy
• Recent Developments
Key Offerings:
• Past Market Size and Competitive Landscape (2022 to 2029)
• Past Pricing and price curve by region (2022 to 2029)
• Market Size, Share, Size and Forecast by different segment | 2022-2029
• Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
• Market Segmentation - A detailed analysis by growth and trend
• Competitive Landscape - Profiles of selected key players by region from a strategic perspective
• Competitive landscape - Market Leaders, Market Followers, Regional player
• Competitive benchmarking of key players by region
• PESTLE Analysis
• PORTER's analysis
• Value chain and supply chain analysis
• Legal Aspects of business by region
• Lucrative business opportunities with SWOT analysis
• Recommendations
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
✆ +1 800 507 4489
✆ +91 9607365656
🖂 mailto:sales@maximizemarketresearch.com
🌐 https://www.maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of the majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PARP Inhibitors Market to reach USD 11.56 Bn by 2029, emerging at a CAGR of 11.20 percent and forecast 2023-2029 here
News-ID: 3278228 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Ginger Market to Grow at a Steady 3.15% CAGR, Targeting USD 9.87 Billion Revenue …
Ginger Market size was valued at USD 7.70 Billion in 2024 and the total Ginger revenue is expected to grow at a CAGR of 3.15% from 2025 to 2032, reaching nearly USD 9.87 Billion.
Ginger Market Overview:
The ginger market is a substantial and vital segment of the spice industry, characterized by its dual role as a staple culinary ingredient and a revered medicinal commodity. Ginger, derived from the rhizome of the…
Acai Berry Market to Grow at an 11.5% CAGR, Targeting USD 18.41 Billion Revenue …
Acai Berry Market size was valued at USD 7.70 Billion in 2024 and the total Acai Berry revenue is expected to grow at a CAGR of 11.5% from 2025 to 2032, reaching nearly USD 18.41 Billion.
Acai Berry Market Overview:
The acai berry market is a dynamic and rapidly growing segment within the superfoods industry, driven by increasing consumer awareness of its high nutritional value and antioxidant properties. Originating from the Amazon…
Coffee Market to Grow at a 6.2% CAGR, Targeting USD 223.25 Billion Revenue by 20 …
Coffee Market size was valued at USD 137.97 Billion in 2024 and the total Coffee revenue is expected to grow at a CAGR of 6.2% from 2025 to 2032, reaching nearly USD 223.25 Billion.
Coffee Market Overview:
The coffee market is a massive and mature agricultural industry, representing one of the world's most traded commodities, second only to oil in some measures. It encompasses the entire supply chain from cultivation and processing…
Indonesia Electric Vehicle Market Valued at US $533.19 Mn in 2022, Projected to …
Indonesia Electric Vehicle Market was valued at US $ 533.19 Mn. in 2022. Indonesia Electric Vehicle Market size is estimated to grow at a CAGR of 20.96%. The market is expected to reach a value of US $ 2020.13 Mn. in 2029.
Indonesia Electric Vehicle Market Overview:
The Indonesia electric vehicle (EV) market is in a nascent but rapidly accelerating stage of development, strategically positioned to become a major hub in the…
More Releases for PARP
PARP Inhibitor Biomarkers Market Size to Expand Lucratively by 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global PARP Inhibitor Biomarkers Market - (By Product (Kits, Assays), By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others), By Application (Breast Cancer, Ovarian Cancer, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global PARP Inhibitor Biomarkers Market is valued at US$ 879.8…
Parp Inhibitors Market Driven by Demand for Immersive Technologies Across Indust …
Global Parp Inhibitors Market Impact of AI and Automation
The PARP inhibitors market has seen remarkable growth in recent years, primarily driven by advances in cancer treatment and the increasing prevalence of cancer globally. These inhibitors, which block the enzyme poly (ADP-ribose) polymerase (PARP), are proving to be highly effective in targeting specific cancer cells, especially in cancers with DNA repair deficiencies like ovarian, breast, and prostate cancers. The approval of…
China Market Analysis of PARP Inhibitors: Growth Opportunities
Global PARP Inhibitors Market: Introduction
A PARP (poly ADP-ribose polymerase) inhibitor is a substance that blocks PARP enzyme in the cell. DNA damage occurs during cancer. Blocking of PARP helps the cancer cells in repairing their damaged part of DNA.
Read Report Overview - https://www.transparencymarketresearch.com/parp-inhibitors-market.html
Global PARP Inhibitors Market: Competition Landscape
Key players operating in the global PARP inhibitors market are AstraZeneca, Tesaro, AbbVie Inc., Medivation, and Clovis Oncology. The global market is…
PARP Inhibitors Market Trends and Segments
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These…
PARP Inhibitors Market Dynamics, Segments, Size and Demand, 2017 - 2027
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These…
Global PARP Inhibitor Market: Size, Trends And Forecasts (2016-2020)
Scope of the Report
The report titled Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-2020) provides an in-depth analysis of the global PARP inhibitor market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Lynparza, Niraparib, Rucaparib, Talazoparib and Veliparib.
The report analyses the global Lynparza market in detail along with the regional analysis as…
